The MR9620-AIM2 is the dual-injector Automatic Injection Module for the Accuris MR9620 SmartReader Multimode Plate Reader — adds two sequential reagent injections per well during the read cycle to the MR9620 chassis for multi-stimulus kinetic workflows. Sold as a set of 2 injectors (two injector units + tubing + reagent reservoirs per the module configuration). Enables BRET assays with substrate + activator, multi-step calcium-flux protocols, dual-substrate kinetic enzyme-activity workflows, and other workflows requiring two precisely-timed reagent injections per well.
Key Specifications
| SKU | MR9620-AIM2 |
| Type | Automatic Injection Module — dual-injector configuration |
| Set quantity | 2 injector units per SKU |
| Compatible chassis | MR9620 SmartReader Multimode Plate Reader (115 V) |
| Function | Dual sequential in-plate reagent injection during the read cycle |
| Workflow examples | BRET assays (substrate + activator), multi-step calcium-flux protocols, dual-substrate kinetic enzyme assays, multi-stimulus drug-screen protocols |
| List price | $11,526 |
What This Module Does
The dual-injector Automatic Injection Module integrates with the MR9620 plate-reader chassis to inject two reagents sequentially into specific wells during the read cycle. The dual-injector configuration enables:
- BRET (bioluminescence resonance energy transfer) assays — inject luciferase substrate and activator sequentially to capture the kinetic BRET signal across both injection-time windows
- Multi-step calcium-flux protocols — inject baseline activator and second-agonist sequentially to capture multi-step calcium mobilization kinetics
- Dual-substrate kinetic enzyme assays — inject two sequential substrates for coupled-enzyme or substrate-cascade workflows
- Multi-stimulus drug-screen protocols — inject control compound and test compound sequentially for drug-screening workflows requiring stimulus comparison within the same well
AIM1 vs AIM2 — Single vs Dual Injection
The MR9620 supports two AIM configurations:
| Module | Injectors | Workflow |
| MR9620-AIM1 | 1 | Single-injection kinetics (luciferase, single-stimulus calcium flux, single-substrate kinetic enzyme) |
| MR9620-AIM2 (this SKU) | 2 | Dual-injection kinetics (BRET, multi-step calcium flux, dual-substrate enzyme cascades) |
Pick the AIM2 when the workflow specifically requires two sequential injections per well (cannot be approximated by a single injection followed by off-instrument addition).
Compatibility & When to Order This SKU
Module pairing — MR9620 chassis only. Order this SKU when:
- Adding dual-injection capability to an MR9620 install — for workflows requiring two precisely-timed injections per well.
- BRET assay workflows — requires sequential substrate + activator injection during the read cycle.
- Multi-step calcium-flux drug-discovery workflows — drug-discovery labs running multi-stimulus calcium-mobilization screens.
- Drug-discovery primary-screen workflows requiring dual-stimulus kinetics — labs running primary screens with sequential agonist / antagonist or substrate / inhibitor injection.
For single-injection workflows, the MR9620-AIM1 sister SKU is the lower-cost option ($6,526 vs $11,526 for the dual configuration).
Application Profile
BRET assays in drug-discovery and signaling research — academic and industry labs running BRET-based protein-protein interaction assays, GPCR signaling assays, and biosensor workflows requiring sequential substrate + activator injection.
Multi-step calcium-flux assays in GPCR drug screens — drug-discovery labs running GPCR primary screens with baseline-activator + test-compound sequential injection.
Dual-substrate kinetic enzyme assays — coupled-enzyme assays, substrate-cascade workflows, and enzyme-inhibitor screens requiring two-substrate kinetics.
Multi-stimulus drug-discovery primary screens — primary-screen workflows where the screening cascade requires sequential stimulus comparison within the same well.
Translational research and drug-discovery on the MR9620 platform — when the MR9620 multimode chassis is the platform for kinetic-injection drug-discovery workflows requiring dual-injection capability.
Ordering & Configuration
Dual-injector setup. The AIM2 ships with two injector units, tubing, and reagent reservoirs per the standard module configuration. Setup requires connecting both injectors to the MR9620 chassis's dedicated injection ports.
Reagent compatibility. The injector materials are typically compatible with most aqueous reagents used in luciferase, BRET, calcium-flux, and kinetic enzyme assays. Confirm reagent chemical compatibility with the injector materials at order if using non-standard reagents.
Software integration. The MR9620's software supports dual-injection AIM-protocol configuration — define injection volumes, sequential timing, and per-well injection schedules.
Confirm at quote: chassis pairing (MR9620 in inventory), workflow assays (BRET, multi-step calcium-flux, dual-substrate kinetic), reagent compatibility, software version, training requirements, and lead time.
Warranty: Per Accuris MR9620 family standard warranty terms — confirm at quote.
MR9620 SmartReader Multimode accessory family:
- MR9620-AIM2 (this product) — Automatic Injection Module, dual injector (sequential dual-injection workflows)
- MR9620-AIM1 — Automatic Injection Module, single injector (single-injection kinetic workflows)
- MR9620-PC — SmartReader Multimode PC Software (Research Version)
- MR9620-CFR — SmartReader Multimode PC Security Software (FDA 21 CFR Part 11)
- MR9610-SDP — SmartDrop Accessory Plate
Pick the AIM2 for dual-injection workflows requiring two sequential reagent additions per well; pick the AIM1 for single-injection kinetic workflows.
